DarioHealth (NASDAQ:DRIO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why

Shares of DarioHealth Corp. (NASDAQ:DRIO) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $11.68 and traded as low as $11.00. DarioHealth shares last traded at $11.25, with a volume of 7,322 shares.

Analysts Set New Price Targets

Several brokerages have recently issued reports on DRIO. TD Cowen restated a “hold” rating on shares of DarioHealth in a report on Friday, November 14th. Wall Street Zen cut shares of DarioHealth from a “hold” rating to a “sell” rating in a research report on Sunday, January 25th. Stifel Nicolaus set a $16.00 price objective on DarioHealth in a report on Friday, November 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $38.00.

DarioHealth Stock Performance

The stock has a market cap of $76.05 million, a PE ratio of -1.01 and a beta of 1.16. The firm’s 50-day moving average is $11.42 and its 200 day moving average is $11.68. The company has a debt-to-equity ratio of 0.41, a quick ratio of 4.02 and a current ratio of 4.55.

Institutional Investors Weigh In On DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. Geode Capital Management LLC boosted its stake in DarioHealth Corp. (NASDAQ:DRIO) by 167.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,567 shares of the company’s stock after acquiring an additional 31,063 shares during the period. Geode Capital Management LLC owned 0.73% of DarioHealth worth $564,000 as of its most recent SEC filing. Institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.